Product Information
TAK-593 is an activator of the N-terminal signaling domain of the erythropoietin receptor that is selective for the erythropoietin receptor. It inhibits tumor growth and induces apoptosis in cancer cells by inhibiting protein synthesis. TAK-593 has been shown to induce tumor regression in mice with lung carcinomas, prostate carcinomas, and breast carcinomas. It also prevents the development of retinal neovascularization in a rat model of oxygen-induced retinopathy and reduces intraocular pressure in rats with experimental glaucoma. TAK-593 is a potent inhibitor of angiogenesis and vascular permeability.
Chemical properties
Technical inquiry about: 3D-FQB78062 TAK-593
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
